Raymond M. Jordt
2023
In 2023, Raymond M. Jordt earned a total compensation of $2.9M as Chief Business Officer at PharmAthene.
Compensation breakdown
| Non-Equity Incentive Plan | $162,000 |
|---|---|
| Option Awards | $1,776,009 |
| Salary | $405,000 |
| Stock Awards | $586,125 |
| Other | $11,850 |
| Total | $2,940,984 |
Jordt received $1.8M in option awards, accounting for 60% of the total pay in 2023.
Jordt also received $162K in non-equity incentive plan, $405K in salary, $586.1K in stock awards and $11.9K in other compensation.
Rankings
In 2023, Raymond M. Jordt's compensation ranked 307th out of 2,647 executives tracked by ExecPay. In other words, Jordt earned more than 88.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 307 out of 2,647 | 88th |
Division Manufacturing | 170 out of 1,447 | 88th |
Major group Chemicals And Allied Products | 116 out of 817 | 86th |
Industry group Drugs | 113 out of 783 | 86th |
Industry Pharmaceutical Preparations | 71 out of 555 | 87th |
Source: SEC filing on August 15, 2024.
Jordt's colleagues
We found two more compensation records of executives who worked with Raymond M. Jordt at PharmAthene in 2023.